Title : Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism.

Pub. Date : 2018 May 28

PMID : 29668854






9 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We have shown previously that oral administration of sulforaphane (SFN) significantly inhibits the incidence and/or burden of prostatic intraepithelial neoplasia and well-differentiated adenocarcinoma in TRansgenic Adenocarcinoma of Mouse Prostate (TRAMP) mice. sulforaphane tumor necrosis factor receptor superfamily, member 25 Mus musculus
2 We have shown previously that oral administration of sulforaphane (SFN) significantly inhibits the incidence and/or burden of prostatic intraepithelial neoplasia and well-differentiated adenocarcinoma in TRansgenic Adenocarcinoma of Mouse Prostate (TRAMP) mice. sulforaphane tumor necrosis factor receptor superfamily, member 25 Mus musculus
3 We have shown previously that oral administration of sulforaphane (SFN) significantly inhibits the incidence and/or burden of prostatic intraepithelial neoplasia and well-differentiated adenocarcinoma in TRansgenic Adenocarcinoma of Mouse Prostate (TRAMP) mice. sulforaphane tumor necrosis factor receptor superfamily, member 25 Mus musculus
4 We have shown previously that oral administration of sulforaphane (SFN) significantly inhibits the incidence and/or burden of prostatic intraepithelial neoplasia and well-differentiated adenocarcinoma in TRansgenic Adenocarcinoma of Mouse Prostate (TRAMP) mice. sulforaphane tumor necrosis factor receptor superfamily, member 25 Mus musculus
5 The present study used cellular models of prostate cancer and archived plasma/adenocarcinoma tissues and sections from the TRAMP study to demonstrate inhibition of fatty acid synthesis by SFN treatment in vitro and in vivo. sulforaphane tumor necrosis factor receptor superfamily, member 25 Mus musculus
6 Immunohistochemistry revealed a significant decrease in expression of FASN and ACC1 proteins in prostate adenocarcinoma sections of SFN-treated TRAMP mice when compared with controls. sulforaphane tumor necrosis factor receptor superfamily, member 25 Mus musculus
7 SFN administration to TRAMP mice resulted in a significant decrease in plasma and/or prostate adenocarcinoma levels of total free fatty acids, total phospholipids, acetyl-CoA and ATP. sulforaphane tumor necrosis factor receptor superfamily, member 25 Mus musculus
8 Consistent with these results, number of neutral lipid droplets was lower in the prostate adenocarcinoma sections of SFN-treated TRAMP mice than in control tumors. sulforaphane tumor necrosis factor receptor superfamily, member 25 Mus musculus
9 Collectively, these observations indicate that prostate cancer chemoprevention by SFN in TRAMP mice is associated with inhibition of fatty acid metabolism. sulforaphane tumor necrosis factor receptor superfamily, member 25 Mus musculus